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Summary
Glucose-inhibited neurons orchestrate behavior and
metabolism according to body energy levels, but
how glucose inhibits these cells is unknown. We stud-
ied glucose inhibition of orexin/hypocretin neurons,
which promote wakefulness (their loss causes narco-
lepsy) and also regulate metabolism and reward.
Here we demonstrate that their inhibition by glucose
is mediated by ion channels not previously implicated
in central or peripheral glucose sensing: tandem-pore
K+ (K2P) channels. Importantly, we show that this elec-
trical mechanism is sufficiently sensitive to encode
variations in glucose levels reflecting those occurring
physiologically between normal meals. Moreover, we
provide evidence that glucose acts at an extracellular
site on orexin neurons, and this information is trans-
mitted to the channels by an intracellular intermediary
that is not ATP, Ca2+, or glucose itself. These results
reveal an unexpected energy-sensing pathway in
neurons that regulate states of consciousness and
energy balance.
Introduction
A fundamental aspect of animal survival is the ability to
react appropriately to changes in life-sustaining energy
supplies. In mammals, the brain plays a central role in
these vital adaptations, detecting changes in body en-
ergy levels and initiating coordinated adjustments in
*Correspondence: dib22@cam.ac.ukbehavior and metabolism (Saper et al., 2002; Schwartz
et al., 2000). One of the earliest explanations for how
the brain monitors body energy levels came from the
discovery of ‘‘glucose-sensing’’ hypothalamic neurons,
which respond to rises in ambient glucose levels with in-
creases (glucose-excited cells) or decreases (glucose-
inhibited cells) in firing rate (Anand et al., 1964; Oomura
et al., 1969). These cells are critical for responding to
the ever-changing body energy state with finely orches-
trated changes in arousal, food seeking, hormone
release, and metabolic rate, to ensure that the brain al-
ways has adequate glucose (Levin et al., 1999; Routh,
2002; Burdakov et al., 2005b). It is therefore important
to understand how glucose exerts its effects on these
neurons.
For most glucose-excited cells, there is now strong
evidence that the excitation involves intracellular glu-
cose entry and closure of ATP-sensitive K+ channels
(Ashford et al., 1990; Routh, 2002). In contrast, the bio-
physical nature of glucose-mediated inhibition (glucose
inhibition) is a long-standing mystery. It has been spec-
ulated that glucose inhibition may involve enhanced
activity of either the sodium pump (Oomura et al., 1974)
or chloride channels (Routh, 2002). However, ion substi-
tution experiments necessary to test these theories
have not been performed. Moreover, even the basic
site of glucose action (intracellular versus extracellular)
in glucose-inhibited neurons is unknown.
Among glucose-inhibited cells are neurons containing
the recently described transmitters orexins/hypocretins
(orexin neurons) (Sakurai et al., 1998; de Lecea et al.,
1998). These cells are highly important regulators of
states of consciousness. They project to all major brain
areas except the cerebellum, with prominent innervation
of key arousal and autonomic regions, where orexins are
released and act on specific G protein-coupled recep-
tors (OX1R and OX2R) (Marcus et al., 2001; Peyron
et al., 1998; Sakurai et al., 1998; Willie et al., 2001; Sut-
cliffe and de Lecea, 2002). Defects in orexin signaling re-
sult in narcolepsy, demonstrating that orexin neurons
are vital for sustaining normal wakefulness (Chemelli
et al., 1999; Lin et al., 1999; Peyron et al., 2000; Than-
nickal et al., 2000; Sutcliffe and de Lecea, 2002). The
activity of orexin neurons also regulates appetite and
metabolic rate, and loss of orexin neurons leads to obe-
sity (Hara et al., 2001). Moreover, key roles for orexin
neurons are emerging in learning, reward seeking, and
addiction (Selbach et al., 2004; Harris et al., 2005; Smith
and Pang, 2005; Borgland et al., 2006).
Considering these crucial roles of orexin neurons, their
recently described inhibition by glucose (Yamanaka
et al., 2003; Burdakov et al., 2005a) is likely to have
considerable implications for the regulation of states of
consciousness and energy balance. However, as in
other glucose-inhibited neurons, it is unknown how glu-
cose suppresses the electrical activity of orexin cells.
Because the sensitivity of orexin cell firing to the small
changes in extracellular glucose that occur between
normal meals has never been tested, the daily physiolog-
ical relevance of their glucose sensing is also unknown.
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tify orexin neurons via targeted expression of GFP in
transgenic mice and document key properties of their
inhibition by glucose. We demonstrate that glucose
inhibition is mediated by activation of ‘‘leak’’ K+ (K2P)
channels (also known as tandem-pore or two-pore do-
main K+ channels), which were not previously implicated
in central or peripheral glucose sensing. Crucially, this
electrical mechanism allows orexin neurons to encode
minute changes in glucose levels reflecting physiologi-
cal variations occurring in the brain between normal
meals. Glucose-modulated K2P channels are activated
by extracellular, but not intracellular, application of glu-
cose. Together, these results identify an unexpected
physiological role for the recently characterized K2P
channels and shed light on the long-elusive mechanism
of glucose inhibition, thus providing new insights into
cellular pathways regulating vigilance states and energy
balance.
Results
Identifying Living Orexin Neurons via Targeted
Expression of eGFP
To identify living orexin neurons in situ, we made trans-
genic mice in which the expression of enhanced green
fluorescent protein (eGFP) is driven by the human pre-
pro-orexin promoter (orexin-eGFP mice; see Experi-
mental Procedures). This proved to be a highly reliable
marker of orexin cells: up to 80% of orexin-containing
neurons in brain slices from orexin-eGFP mice were la-
beled with eGFP, as in previous studies of eGFP expres-
sion driven by this promoter (Li et al., 2002; Yamanaka
et al., 2003). Expression of orexin in 100% of eGFP neu-
rons (Figure 1A) was further confirmed by scanning indi-
vidual cells (n = 70) at high magnification.
To study electrical activity of orexin neurons, we per-
formed whole-cell patch-clamp recordings in acutely
isolated brain slices. Exactly like wild-type mouse orexin
neurons (Burdakov et al., 2005a), eGFP-containing neu-
rons exhibited spontaneous electrical activity (Figure 1B;
n = 20) and were inhibited when the extracellular solution
was switched from 0.2 to 4.5 mM glucose (Figure 2A, n =
19/20). This confirmed that transgenic eGFP expression
does not disrupt intrinsic electrophysiology and glucose
sensing of mouse orexin neurons, which is also sug-
gested by previous reports (Li et al., 2002; Yamanaka
et al., 2003).
Biophysical Identity of the Current Responsible
for Glucose Inhibition
To address the ionic nature of glucose inhibition, we
combined intracellular ion substitutions with whole-cell
recordings. First, we used a K-gluconate intracellular
solution; in its presence, glucose induced hyperpolar-
ization (Figure 2A). With this solution, the current re-
sponsible for hyperpolarization can be carried by two
ions, K+ and Cl–, since only these ions have equilibrium
(Nernst) potentials (Eion) that are more negative than
resting membrane potentials of orexin cells (EK = 2103
mV, ECl =258 mV). This indicates that glucose inhibition
is mediated by K+ or Cl– currents.
Next, we used a KCl intracellular solution (which was
also used in all subsequent experiments). This solutionsets ECl to w0 mV, making K
+ channels the only ion
channels that can hyperpolarize resting potentials of
orexin cells. Under these conditions, glucose still pro-
duced pronounced hyperpolarization (Figure 2A, n =
38/41). This indicates that a K+, and not Cl–, current is
responsible. Thus, the net glucose-induced current
should have an equilibrium potential corresponding to
EK. We isolated the net glucose-induced current by
subtracting whole-cell currents in 0.2 mM extracellular
glucose from those recorded from the same cell in 4.5
mM glucose (Figures 2A and 2B). Glucose-induced cur-
rent (Figure 2C) had an equilibrium potential of21046 1
mV (n = 30), confirming its high selectivity for K+ ions
(EK = 2103 mV). Direct injections of currents of similar
size into orexin neurons mimicked hyperpolarization
produced by glucose (Figure 2F), confirming that the
glucose-induced current was large enough to account
for glucose inhibition.
The K+ channel families fall into three groups based on
voltage and Ca2+ dependence of their currents: (1) volt-
age- and/or Ca2+-gated channels, (2) inwardly rectifying
channels, and (3) leak channels exhibiting Goldman-
Hodgkin-Katz (GHK) outward rectification (Hille, 2001).
To determine which of these channel families mediates
glucose inhibition, we focused on the current-voltage
(I-V) relationship of the net glucose-induced current
(Figure 2C). This showed clear outwardly rectifying be-
havior that was well described by the GHK current equa-
tion (Figure 2C). This is strongly indicative of a leak K+
conductance lacking intrinsic voltage dependence,
whereas K+ channels of types (1) and (2) (above) have
strikingly different I-V relationships (Hille, 2001).
Glucose-induced current was also unaffected by fix-
ing cytosolic [Ca2+] at 90 nM with an intracellularly ap-
plied BAPTA-Ca2+ mixture (n = 15, see Figure 7D and
associated text), providing a further strong argument
against involvement of Ca2+-activated K+ currents
(Gribkoff et al., 2001). Overall, the properties of glu-
cose-induced currents were thus consistent with leak
K+ channels but not with other K+ channel families. Ana-
lyzing the time course of net glucose-induced currents
evoked in response to voltage steps revealed rapid
activation and minimal time-dependent decay (Figures
Figure 1. Properties of eGFP-Expressing Neurons from Orexin-
eGFP Mice
(A) Imaging of eGFP (green) and immunolabeled orexin-A (red).
Colocalization of eGFP and orexin-A is shown in yellow. Scale bar,
100 mm.
(B) Current-clamp recording from an orexin-eGFP neuron showing
intrinsic activity.
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Activated Current in Orexin Neurons
(A) Effects of elevating extracellular glucose
from 0.2 to 4.5 mM on membrane potential
with K-gluconate (top) and K-chloride (bot-
tom) pipette solutions. Arrows indicate
when currents shown in (B) were recorded.
(B) Effects of glucose on membrane I-V rela-
tionship of the cell in (A).
(C) I-V plot of net glucose-activated current
(n = 6). The line is a fit of the GHK equation
to the data (see Experimental Procedures for
fitting parameters). Data are means6 SEM.
(D) Effects of glucose on membrane currents
obtained with voltage steps. Currents were
produced by steps to 280, 270, 260, and
250 mV (from 290 mV).
(E) Time course of activation and inactivation
of net glucose-activated currents (high glu-
cose minus low glucose), obtained by steps
to 270 and 260 mV (from 290 mV).
(F) Effects of current injections on an orexin
cell: 15 (top), 30 (middle), and 45 (bottom) pA
(the current-clamp protocol is shown sche-
matically below).2D and 2E). These kinetic features are further typical
attributes of leak K+ channels (Goldstein et al., 2001).
Modulation of Glucose-Induced Currents
by Halothane and Acid
Together, the K+ selectivity, GHK outward rectification,
rapid activation, and minimal inactivation indicated the
involvement of K+-selective leak channels. In mammals,
such leak K+ channels are made up of K2P protein sub-
units, encoded by the KCNK gene family (Lesage andLazdunski, 2000; Patel and Honore, 2001; Goldstein
et al., 2001). This family has 15 genes, most of which pro-
duce functional ion channels upon expression (Gold-
stein et al., 2005). Different subfamilies of these K2P
channels exhibit different responses to certain modula-
tors. Notably, halothane activates K2P channels belong-
ing to ‘‘TASK’’ or ‘‘TREK’’ subfamilies, but inhibits
channels of ‘‘THIK’’ and ‘‘TALK’’ subfamilies (reviewed
in O’Connell et al., 2002). Of these, TASK K2P channels
are potently inhibited by extracellular acid, which,
Neuron
714Figure 3. Effects of Halothane on Orexin Neu-
rons
(A) Effect of halothane (1%) on membrane
potential.
(B) I-V relationship of net halothane-induced
current from cell shown in (A). The red line is
a fit of the GHK equation to the data.
(C) Effect of glucose in the presence of halo-
thane (1%). The cell was first hyperpolarized
by halothane, then returned to prehalothane
potential by current injection (the current-
clamp protocol is shown below the trace).
Arrows indicate when the currents shown in
(D) were recorded.
(D) Effects of halothane and glucose on mem-
brane I-V relationship of the cell shown in (C).together with activation by halothane and GHK rectifica-
tion, is among the best diagnostic tests for TASK K2P
channels (Bayliss et al., 2003).
In our experiments, halothane (1%, based on Meuth
et al., 2003) mimicked actions of glucose on the mem-
brane potential (Figure 3A, n = 5), an effect that was not
readily reversed in our slice preparations. The net halo-
thane-induced currents were identical to glucose-
induced currents in GHK rectification (Figure 3B), activa-
tion/inactivation kinetics (data not shown), and reversal
potentials (2104 6 3 mV), in four out of six cells. In the
remaining two cells (which were not used for analysis),
halothane-induced current reversed at potentials posi-
tive to EK (280 and 275 mV), indicating that, in some
orexin cells, halothane also modulates other ion cur-
rents, as reported for other neurons (Meuth et al., 2003).
To examine the actions of glucose in the presence of hal-
othane, halothane-hyperpolarized cells were returned to
control (prehalothane) membrane potentials by current
injection (Figure 3C). Subsequent glucose application
still induced hyperpolarization and further activated the
halothane-induced current (Figures 3C and 3D, n = 5),
regardless of whether the halothane-activated currents
were large or small. This indicated that halothane did
not fully activate the current, consistent with previous
data showing that halothane cannot by itself attain the
maximal open state of K2P channels (Sirois et al., 2000).
Overall, these effects of halothane implicated either
TASK or TREK K2P channels.
We next tested the effect of extracellular acid, which
clearly reversed the effects of glucose on the membrane
potential and current of orexin cells (Figures 4A and 4B,
n = 15). The net acid-inhibited currents were indistin-
guishable from glucose-induced currents in GHK rectifi-
cation (Figure 4D, n = 7), reversal potentials (2102 6 1,
n = 7), and activation/inactivation kinetics (n = 5, data
not shown). Extracellular acidification from pH 7.3 to
5.9 acted as a selective way of blocking glucose-acti-
vated channels, because at 0.2 mM of glucose (whenglucose-activated channels are closed) acidification
did not affect the membrane potential or currents (Fig-
ure 4C, n = 4). This allowed us to test whether impairing
the function of glucose-activated channels with low ex-
tracellular pH would prevent glucose responses. On the
background of pH 5.9, glucose failed to induce any
changes in the membrane potential or currents of orexin
cells (Figure 4C, n = 5). We confirmed that glucose-mod-
ulated channels were present in all of these cells by re-
turning pH to the control value of 7.3; we first observed
a rapid unmasking of glucose responses, followed by
normal responses to further applications of glucose
(Figure 4C, n = 5).
In summary, glucose-induced currents exhibit GHK
outward rectification, inhibition by extracellular acid,
and activation by halothane. Among cloned ion chan-
nels, TASK K2P channels are at present unique in exhib-
iting this combination of attributes (Bayliss et al., 2003).
Thus our data imply that TASK K2P channels mediate
glucose inhibition.
Evidence for TASK3 Subunits in Glucose-Activated
Channels
We saw half-maximal inhibition (IC50) of glucose-
induced current at a pH of 6.9 (Figure 4E). This has impli-
cations for the channel identity, because different TASK
channels have different sensitivities to acid, as illus-
trated by their IC50 pH values:w7.3 for TASK1 (K2P3.1),
w8.3 for TASK2 (K2P5.1), w6.7 for TASK3 (K2P9.1), and
w10 for TASK4 (K2P17.1) (reviewed in O’Connell et al.,
2002). The measured value of 6.9 is closest to channels
containing TASK3 subunits, such as TASK3 homomers
or TASK3-containing heteromeric channels (Czirjak
and Enyedi, 2002; O’Connell et al., 2002; Berg et al.,
2004; Kang et al., 2004). However, the high variation of
published IC50 values (e.g., Berg et al., 2004; Rajan
et al., 2000) makes it difficult to rule out channels with
a similar IC50, e.g., TASK1, on the basis of acid sensitivity
alone.
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cose Responses of Orexin Neurons
(A) Effects of changes in pH on glucose-
induced hyperpolarization.
(B) Effects of changes in pH on glucose-
induced currents.
(C) Glucose does not affect membrane poten-
tial (left) and current (right) when pH is low
(control extracellular solution is at a pH of 7.3).
(D) Net current inhibited by extracellular acid-
ification (current at pH 7.3 minus current at pH
6, both in 4.5 mM glucose). The red line is a fit
of the GHK equation to the data.
(E) Dose-response of acid-induced inhibition
of glucose-activated currents (measured at
260 mV) (n = 5). The line is a fit of the Hill equa-
tion to the data (see Experimental Proce-
dures), IC50 is at a pH 6.9. Data are means
6 SEM.
Experiments performed in 1 mM tetrodotoxin.Single-channel conductance provides a more accu-
rate way of distinguishing TASK3-containing channels
from TASK1 homomers (Bayliss et al., 2003; Kang
et al., 2004). We measured single-channel activity using
cell-attached recordings (with no glucose in the pipette;
see Experimental Procedures). Glucose-activated chan-
nels were observed in six out of eight cell-attached
patches (Figures 5A and 5B), but not in five out of five
patches recorded using acidic (pH = 5.9) pipette solu-
tions, as expected from whole-cell data (Figure 4). These
channels exhibited flickering on-off kinetics typical of
TASK channels (e.g., Kang et al., 2004; Leonoudakis
et al., 1998) and had a conductance of 40 6 1 pS (Fig-
ure 5C, n = 6 channels). This value is different from con-
ductances of TASK1 homomers (w14 pS), but is in good
agreement with TASK3-containing channels, which
have conductances of 38.1 6 0.7 pS (TASK3-containing
heteromers) or 30–37.8 pS (TASK3 homomers) (Bayliss
et al., 2003; Kang et al., 2004).
To distinguish between TASK3 homomers and
TASK3-containing heteromers (which are biophysically
identical), we used ruthenium red. It is well established
that at 5–10 mM, this drug blocks TASK3 homomers
byw80%, but has little effect on TASK3-containing het-
eromers (Czirjak and Enyedi, 2002; Kang et al., 2004;
Berg et al., 2004). We found no inhibitory effect of
10 mM ruthenium red on the glucose-induced current
(Figure 5D, n = 4).The pharmacological and biophysical profile of glu-
cose-activated channels thus implicated heteromeric
channels containing TASK3 subunits. In further corrob-
oration of this conclusion, we detected TASK3 proteins
in orexin neurons using two different antibodies (Fig-
ure 5E, n > 20 for each antibody; antibodies are de-
scribed in Experimental Procedures). This is in agree-
ment with high levels of TASK3 mRNA in the lateral
hypothalamus (Talley et al., 2001), where orexin neurons
are clustered (Yamanaka et al., 2003). Hence, both
functional and molecular data support the idea that
glucose-activated channels contain TASK3 subunits.
The importance of these subunits is that they determine
the single-channel biophysics and anesthetic and trans-
mitter sensitivity of K2P channels, even when combined
with other pore-forming subunits such as TASK1 (Kang
et al., 2004; Talley and Bayliss, 2002). Here, we did not
further address the nature and significance of such other
subunits, although we observed binding of an antibody
against TASK1 to orexin neurons (Figure 5F, n = 20 cells),
which is in agreement with overlapping expression of
TASK3 and TASK1 mRNA in the lateral hypothalamus
(Talley et al., 2001).
Control of Orexin Cell Firing by Small Physiological
Changes in Glucose Levels
As mentioned above, it is unknown whether the small
changes in extracellular glucose that occur between
Neuron
716Figure 5. Properties of Glucose-Activated
Channels in Orexin Neurons
(A) Cell-attached recording with no glucose in
the pipette (the scheme of recording is above
the trace; see Experimental Procedures for
details). Closed (c) and open (o) states are in-
dicated approximately with arrowheads. The
electrode potential was zero.
(B) (Top) Cell-attached recordings of glucose-
activated channels at different estimated
patch potentials (see Experimental Proce-
dures). (Bottom) Amplitude histogram of
single-channel events at an estimated patch
potential of 280 mV. Red lines are individual
Gaussian fits; black line is the sum of these
fits. Data are means 6 SEM.
(C) Amplitudes of single-channel currents
(determined from Gaussian fits such as that
shown in [B]) at different estimated patch po-
tentials (n = 4). The slope of the line fitted
through the points is 0.04 pA/mV (40 pS).
(D) Whole-cell recording of the effect of ruthe-
nium red (RR) on glucose-induced changes in
membrane potential (left) and current (right).
(E) Detection of TASK3 proteins (red) in orexin
neurons (green) with two different antibodies
(Anti-TASK3 1 and 2, see Experimental Proce-
dures). Scale bars, 10 mm.
(F) Staining of orexin neurons with an anti-
body against TASK1 (blue), and overlay of
TASK3 staining in the same cell (colocaliza-
tion is shown in pink). Scale bar, 10 mm.
Experiments performed in 1 mM tetrodotoxin.normal meals can affect the firing rate of orexin cells.
Brain interstitial glucose levels are typically 10%–30%
of plasma glucose levels, and the experiments per-
formed above involved switching between the lowest
(0.2 mM) and highest (4.5 mM) extremes of brain glu-
cose, likely to correspond to starvation and eating
a very large meal, respectively (Routh, 2002; Silver and
Erecinska, 1994). Variations in glucose levels in mamma-
lian brains that occur between normal meals are muchmore subtle, between 1 and 2.5 mM (Routh, 2002). To
provide evidence for the involvement of glucose inhibi-
tion of orexin cells in normal physiology, it is crucial to
establish if their glucose-sensing machinery is suffi-
ciently sensitive to translate such small variations in
glucose into different firing rates.
Switching from 1 to 2.5 mM extracellular glucose
evoked marked hyperpolarization and suppressed firing
in all orexin neurons tested (Figure 6A, n = 7). The firing
Mechanism of Glucose Inhibition of Orexin Neurons
717Figure 6. Sensing of Subtle Changes in Glu-
cose Concentration by Orexin Neurons
(A) Effects of switching between 1 and 2.5
mM extracellular glucose on membrane po-
tential. Arrows show when voltage-clamp
ramps in (B) were recorded.
(B) Effects of glucose on membrane currents
of the orexin neuron shown in (A).
(C) I-V relationship of net glucose-activated
current in the neuron shown in (A). The red
line is a fit of the GHK equation to the data.rate decreased dramatically from 4.56 1 Hz in 1 mM glu-
cose to 0.026 0.01 Hz in 2.5 mM glucose (p < 0.001, n =
5). The net current activated by this physiological rise in
glucose showed the same properties as in the previous
sections: GHK rectification and a reversal potential cor-
responding toEK (21036 2 mV, Figure 6B and 6C, n = 5),
rapid activation, little or no inactivation, and inhibition by
extracellular acid (n = 4, data not shown).
These results provide evidence that the firing rate of
orexin cells is sensitive to changes in glucose that corre-
spond to fluctuations occurring normally during the day
and also show that the same electrical mechanism is in-
volved in sensing both subtle and extreme changes in
glucose.
Coupling between Extracellular Glucose
and Membrane Currents
To determine whether glucose acts intracellularly or ex-
tracellularly, we applied it selectively to the inside of the
cell. The rationale for this experiment is that if intracellu-
lar action of glucose is important, then increasing glu-
cose levels inside the cell should reproduce the effects
of extracellular glucose. Conversely, if glucose acts ex-
tracellularly, then intracellular glucose should neither
reproduce nor prevent the effects of extracellular glu-
cose. This is a classical experimental strategy, which
was used, for example, to show that peptide hormones
exert their action by acting extracellularly and not intra-
cellularly (Philpott and Petersen, 1979). The whole-cell
patch-clamp mode is a powerful and widely used way
of applying chemicals inside cells, since it makes the
interior of the pipette continuous with the cytosol, allow-
ing intracellular infusion of pipette contents. Using an
intracellular tracer, we previously confirmed that orexin
neurons become thoroughly filled with pipette solution
within 5–10 min after establishing whole-cell mode (Bur-
dakov et al., 2005a).
To evaluate the possibility that glucose acts intra-
cellularly, as assumed for glucose-excited neurons(reviewed in Burdakov et al., 2005b), we added 5 mM
glucose to the pipette and dialyzed orexin cells with
this solution for 10–20 min in the whole-cell mode. This
neither mimicked nor prevented the electrical actions
of extracellular glucose (Figures 7A and 7B, n = 6).
Thus, glucose itself did not appear to act as an intra-
cellular messenger mediating electrical inhibition of
orexin neurons. Rather, its electrically important actions
are mediated by action on an extracellular site (see
Discussion).
We followed the same rationale to evaluate possible
roles for ATP and Ca2+, since these intracellular messen-
gers can act as modulators of membrane currents (Ash-
croft, 1988; Petersen et al., 1994). In all whole-cell exper-
iments described above, the cells were already dialyzed
with higher [ATP] (5 mM) than typical physiological
levels in hypothalamic neurons (about 1 mM, Ainscow
et al., 2002). This neither reproduced nor prevented the
effects of glucose (e.g., Figure 2A). To increase ATP
levels still further, we loaded cells with a supraphysiolog-
ical concentration of ATP (10 mM ATP in pipette). Again,
this was without effect (Figure 7C, n = 15). These results
argue strongly against any dominant role for changes in
cytosolic [ATP] in responses of orexin cells to glucose,
consistent with recent evidence that cytosolic [ATP] is
not influenced by changes in extracellular glucose in
hypothalamic neurons (Ainscow et al., 2002).
Dialyzing the cells with pipette solutions containing
the fast Ca2+ buffer BAPTA (10 mM) combined with 2
mM Ca2+ (to clamp cytosolic [Ca2+] atw90 nM, Mogami
et al., 1998) did not prevent the electrical effects of glu-
cose (Figure 7D, n = 15), suggesting that changes in Ca2+
levels are not essential for these effects. Glucose inhibi-
tion also persisted when Ca2+ influx into the cell was
suppressed using a low Ca2+/high Mg2+ extracellular
solution (see Experimental Procedures) (Figure 7E, n =
4). These data suggest that neither Ca2+ entry nor Ca2+
mobilization from intracellular stores is critical for glu-
cose inhibition.
Neuron
718Figure 7. Effects of Putative Intracellular
Messengers on Glucose Responses of
Orexin Neurons
(A) Intracellular (pipette) glucose (5 mM)
elicits no inhibition and does not prevent a
response to extracellular glucose. The begin-
ning of the trace corresponds to the moment
when the whole-cell mode was established.
(B) Effects of intracellular and extracellular
glucose on membrane I-V relationship of an
orexin neuron. Five millimolar glucose was
continuously present in the pipette in whole-
cell mode. Extracellular glucose was elevated
to 4.5 mM at 7.5 min and returned to the
control value of 0.2 mM at 10.5 min.
(C) Effects of glucose on the membrane po-
tential (left) and current (right) in a cell dia-
lyzed with 10 mM ATP for 20 min prior to
recording of the trace shown.
(D) Effects of glucose on the membrane po-
tential (left) and current (right) in a cell dia-
lyzed with 10 mM BAPTA/2 mM Ca+ for 20
min prior to recording of the trace shown. Ar-
rows show when voltage-clamp ramps were
recorded.
(E) Effects of glucose on the membrane po-
tential (left) and current (right) in a low Ca2+/
high Mg2+ extracellular solution.Discussion
Despite the importance of glucose-inhibited neurons for
regulation of arousal states, appetite, and metabolism,
the electrical mechanism of glucose inhibition and the
basic site of glucose action (intracellular versus extra-
cellular) were unknown. Here we identify three unex-
pected features of glucose inhibition of orexin neurons,
which control states of consciousness and metabolism.
First, glucose inhibition is mediated by K2P channels
(Figure 2), an electrical mechanism of energy sensing
that was not previously suspected in the brain or else-
where. This identifies an important function for K2P
channels, a recently characterized channel family with
few currently known physiological roles. Second, this
electrical pathway enables orexin cells to detect fluctua-
tions in glucose corresponding to physiological changes
occurring between normal fed and fasted states(Figure 6). This provides evidence that normal daily var-
iations in brain glucose levels can exert powerful control
on the firing of orexin cells. Third, glucose acts extracel-
lularly and not intracellularly (Figures 7A and 7B). Our
results thus provide important new insights into how
the brain tunes arousal and metabolism according to
body energy levels.
Electrical Mechanism of Glucose Inhibition
Several K2P channels are expressed in mammalian
brains (Hervieu et al., 2001; Kindler et al., 2000; Medhurst
et al., 2001; Talley et al., 2001), yet so far relatively few
physiological roles for them have emerged. Notably,
acid-sensing TASK channels in the brain stem are
thought to trigger adaptive increases in arousal when
brain pH falls (Bayliss et al., 2003; Talley et al., 2003).
In addition, K2P channels are involved in regulating ex-
citability of cerebellar granule (Brickley et al., 2001;
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(Meuth et al., 2003), supraoptic (Han et al., 2003), and
dorsal vagal neurons (Hopwood and Trapp, 2005), but
the physiological roles of these effects remain to be
elucidated. It is intriguing to uncover a role for these re-
cently described channels in the long-elusive mecha-
nism of glucose inhibition. Since these channels have
not been previously implicated in glucose sensing or
hypothalamic detection of other messengers, it would
be interesting to test if they play similar roles in other
glucose-inhibited cells.
In addition to GHK rectification, leak-like kinetics, and
K+ selectivity, glucose-activated currents displayed the
following properties: (1) block by extracellular acid with
an IC50 at pH 6.9 (Figure 4E), (2) potentiation by halo-
thane (Figure 3), (3) single-channel conductance of
w40 pS (Figures 5A–5C), and (4) insensitivity to ruthe-
nium red (Figure 5D). Together, this provides strong ev-
idence for the involvement of heteromeric K2P channels
containing TASK3 subunits. Indeed, we detected TASK3
subunits in lateral hypothalamic orexin neurons using
two different antibodies (Figure 5E), which is consistent
with the high expression of TASK3 mRNA in this brain
region (Talley et al., 2001).
However, it remains a formal possibility that other K2P
subunits play a role, which could be functionally similar
or identical to TASK3, but are not yet fully characterized.
For example, subunits that are currently thought to be
nonfunctional, e.g., TASK5 (K2P15.1), could play a role
once activated through mechanisms similar to that re-
cently revealed for the formerly ‘‘nonfunctional’’ K2P1.1
(Rajan et al., 2005). Elucidating the full molecular com-
position of glucose-modulated K2P channels is an inter-
esting subject for future investigation; its unequivocal
resolution would require manipulation of multiple
KCNK genes and protein-protein interaction analyses
in orexin cells.
Coupling between Extracellular Glucose
and Electrical Activity
Intracellular application of glucose or ATP neither repro-
duced nor precluded the effects of extracellular glucose
(Figures 7A–7C). Preventing cytosolic Ca2+ rises also
had no effect on responses to glucose (Figures 7D and
7E). These data support a general mechanism of glu-
cose sensing whereby glucose acts at an extracellular
site and information is transmitted to membrane chan-
nels by an intracellular intermediary that is not ATP,
Ca2+, or glucose itself (Figure 8A). Traditional models
by which glucose is thought to influence neuronal elec-
trical activity involve either neuronal glucose entry and
metabolism (Figure 8B) (Routh, 2002) or glial conversion
of glucose to lactate (Figure 8C) (Ainscow et al., 2002;
Pellerin and Magistretti, 2004). Our results provide evi-
dence for a different mechanism in glucose-inhibited
neurons (Figure 8A).
The extracellular target on which glucose acts is
located on orexin neurons themselves, because they
continue to sense glucose when synaptically isolated
using tetrodotoxin (Figure 4A) or low extracellular Ca2+
(Figure 7E), as well as when studied in isolated cell prep-
arations (Yamanaka et al., 2003). However, the appear-
ance of glucose-activated channels in patches that do
not have glucose on the extracellular side (Figures 5Aand 5B) suggests that glucose does not act on the extra-
cellular side of the channels themselves. Perhaps extra-
cellular glucose receptors such as those identified in
yeast (Holsbeeks et al., 2004) could be involved, but it
is currently unknown whether similar molecules operate
in mammalian brains.
Implications for Control of Behavioral
and Metabolic States
Orexin cells are critical for promoting wakefulness and
regulating metabolism and reward, and so the new
mechanism of their regulation described here could
contribute to these vital processes. Importantly, we
demonstrate that the glucose-sensing machinery of
orexin neurons is sufficiently sensitive to translate small,
nonextreme, physiological fluctuations in glucose into
substantial changes in firing rate (Figure 6). This raises
the possibility that, besides being important for adaptive
responses to starvation, modulation of orexin cells by
glucose has a much wider behavioral role, contributing
to the continuous daily readjustments in the level of
arousal and alertness. The reversal of glucose inhibition
by extracellular acid (Figure 4) may also have important
Figure 8. Schematic Cartoons of How Glucose Can Influence Elec-
trical Activity
(A) Glucose can bind to extracellular sites and trigger intracellular
transduction pathways regulating membrane channels such as K2P.
(B) Glucose can enter cells via electrogenic or nonelectrogenic path-
ways, and be metabolized inside neurons to ATP, which inhibits
plasmalemmal KATP channels.
(C) Glia (astrocytes) can convert glucose to lactate, which is then
metabolized further inside neurons to produce ATP.
See Discussion for more detail.
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most pronounced (Figure 4E) within the physiological
range of brain pH (6.9 to 7.4, Kintner et al., 2000). It is
therefore possible that situations leading to acidification
of brain interstitial space, such as an excessive reduc-
tion of breathing during sleep for example (Phillipson
and Bowes, 1986), may override glucose inhibition of
orexin neurons when it is necessary to increase arousal
despite high energy levels.
Experimental Procedures
Generation of Transgenic Mice
Mice were made transgenic for eGFP, a red-shifted variant of the
wild-type GFP that has been optimized for brighter fluorescence
and higher expression in mammalian cells. Expression of eGFP
was driven by the human prepro-orexin promoter kindly donated
by Dr. Takeshi Sakurai. A 3.2 kb SacI-SalI fragment containing the
50 flanking region and noncoding region of the prepro-orexin gene
was excised from the construct used for the generation of human
prepro-orexin-nlacZ transgenic mice (Sakurai et al., 1999) and
cloned into the MCS of the pEGFP-1 vector (Clontech Laboratories,
Inc, CA). A 4 kb SacI-AflII fragment containing the promoter and
eGFP, including SV40pA signals, was excised and injected into
fertilized mouse eggs from B6D2 (DBA/2xC57BL/6 F1) mice. Viable
embryos were subsequently transferred to the oviducts of pseudo-
pregnant B6D2 females for development to term. Transgenic off-
spring were identified by PCR amplification of tail DNA using primers
specific for the prepro-orexin-eGFP sequence, and by expression of
eGFP in orexin neurons (Figure 1A).
Electrophysiology
Whole-Cell Recordings
Procedures involving animals were carried out in accordance with
the Animals (Scientific Procedures) Act, 1986 (UK). Coronal slices
(300 mm thick) containing the lateral hypothalamus were obtained
from orexin-eGFP mice (16–21 days old) as previously described
(Burdakov et al., 2004). Experiments were performed at room tem-
perature (24ºC–26ºC). Extracellular solution was ACSF gassed with
95% O2 and 5% CO2 and contained (in mM) NaCl, 125; KCl, 2.5;
MgCl2, 2; CaCl2, 2; NaH2PO4, 1.2; NaHCO3, 21; HEPES, 10; glucose,
0.2; pH = 7.3 with NaOH (based on brain interstitial pH in vivo, Kintner
et al., 2000). ASCF [glucose] was 0.2 mM unless indicated otherwise.
The small osmolarity changes associated with changing [glucose] in
ASCF were either compensated with sucrose or left uncompen-
sated; no differences were observed between the two conditions.
‘‘Low Ca2+/high Mg2+’’ ACSF contained 0.3 mM Ca2+ and 9 mM
Mg2+ (Burdakov et al., 2003). Where indicated, ACSF pH was altered
by addition of NaOH or HCl. ‘‘K-gluconate’’ intracellular (pipette)
solution contained (in mM) K-gluconate, 120; KCl, 10; EGTA, 0.1;
HEPES, 10; K2ATP, 4; Na2ATP, 1; MgCl2, 2; pH = 7.3 with KOH.
‘‘KCl’’ intracellular solution contained (in mM) KCl, 130; EGTA, 0.1;
HEPES, 10; K2ATP, 5; NaCl, 1; MgCl2, 2; pH = 7.3 with KOH. All the
chemicals were from Sigma.
Neurons were visualized using an Olympus BX50WI upright mi-
croscope equipped with infrared gradient contrast optics (Dodt
et al., 2002), a mercury lamp, and filters for visualizing eGFP-contain-
ing cells. Current- and voltage-clamp whole-cell recordings were
performed using an EPC-9 amplifier (Heka, Lambrecht, Germany).
In current-clamp experiments, the holding current was zero unless
indicated otherwise. Patch pipettes were pulled from borosilicate
glass and had tip resistances of 2–3 MU when filled with the ‘‘KCl’’
pipette solution. Series resistances were in the range of 5–8 MU
and were not compensated. Data were sampled and filtered using
Pulse/Pulsefit software (Heka, Lambrecht, Germany) and analyzed
with Pulsefit and Origin (Microcal, Northampton, MA) software.
Steady-state membrane I-V relationships (Figure 2C) were obtained
using 500 ms long hyperpolarizing and depolarizing voltage-clamp
steps from a holding potential of 290 mV. Alternatively, I-Vs were
obtained by ramping the membrane potential from 0 to 2140 mV
at a rate of 0.1 mV/ms, which was sufficiently slow to allow the K+current to reach steady state at each potential (Meuth et al., 2003).
Data are given as mean 6 SEM.
Where indicated, I-Vs were fitted with the Goldman-Hodgkin-Katz
(GHK) current equation (Hille, 2001), in the following form:
I=PKz
2VF
2
RT
½K+ i 2 ½K+ oexpð2 zFV=RTÞ
12expð2 zFV=RTÞ
Here, I is current, V is membrane potential, z is the charge of
a potassium ion (+1), [K+]i is the pipette K
+ concentration, [K+]o is
the ACSF K+ concentration, T is temperature (298.15 K, correspond-
ing to 25ºC), and R and F have their usual meanings (Hille, 2001). PK
(a constant reflecting the K+ permeability of the membrane) was the
only free parameter during fits. The values of PK used to obtain the
fits shown were 0.0176 (Figure 2C), 0.03485 (Figure 3B), 0.0439
(Figure 4D), and 0.0202 (Figure 6C).
Dose-response relation for acid-induced inhibition of glucose-
activated current (I) was fitted with a modified Hill equation:
I= Imax2 Imax
½H+ h
ICh50 + ½H+ h
Here, Imax is the maximal current, [H
+] is the extracellular proton
concentration, IC50 is the value of [H
+] at which the inhibition is half-
maximal, and h is the Hill coefficient. The fit shown in Figure 4E was
obtained with the following parameters: Imax = 171 pA, h = 1.2, IC50 =
127 nM (equivalent to pH of 6.9).
Single-Channel Recordings
For cell-attached recordings from cell bodies of orexin neurons,
patch-pipettes were filled with a high K+ solution containing (in
mM) KCl 120, EGTA 11, CaCl2 1, MgCl2 2, HEPES 10, adjusted to
pH 7.25 with 35 mM KOH (final K+ concentration 155 mM) (Verheu-
gen et al., 1999). In neurons, using this solution results in sufficiently
symmetrical K+ concentrations on the two sides of the cell-attached
patch to justify the assumption that EK in the patch isz 0 mV (Ver-
heugen et al., 1999). When the membrane potential is negative and
the electrode potential is zero, K+ currents thus appear as inward
currents (Figures 5A and 5B). Data were sampled at 10 kHz and fil-
tered at 3 kHz. All other experimental conditions were the same as
for whole-cell recordings. Only patches with no channel activity in
control (0.2 mM glucose) ASCF were used for further experimenta-
tion, and channel amplitudes were determined in patches judged
to contain one glucose-activated channel. Estimated values of the
patch potential (obtained as in Verheugen et al., 1999) were in close
agreement with whole-cell data: 10 min after applying 4.5 mM glu-
cose, patch and whole-cell potentials were 280 6 3 mV and 281
6 2 mV, respectively (n = 4 cells for each case). Single-channel con-
ductances were calculated from slopes of linear fits (Origin) of chan-
nel I-V relationships (Figure 5C). We also performed cell-attached
recordings of glucose-activated channels using pipette solution
from Kang et al. (2004), which yielded similar channel conductances
(38 6 2 pS, n = 3 patches, data not shown).
Immunocytochemistry and Confocal Imaging
Immunolabeling for orexin-A was performed as in our previous stud-
ies (Burdakov et al., 2004, 2005a). For detection of K2P proteins, the
brains of orexin-eGFP mice were fixed in 4% PFA at 4ºC for 24 hr and
then cut in PBS into 150–200 mm coronal sections. Slices were incu-
bated for 20 min in a blocking medium containing 10% horse serum,
0.2% BSA, and 0.5% Triton in PBS, followed by two washes in PBS.
For detection of TASK3 we used two different antibodies. Antibody
(1) in Figure 5E was a goat polyclonal antibody (Rusznak et al., 2004;
Yamamoto and Taniguchi, 2003) raised against a peptide mapping
to the C terminus of TASK3 of rat origin (1:100, Santa Cruz Biotech-
nology, CA). Antibody (2) in Figure 5E was a rabbit polyclonal anti-
body raised against an epitope corresponding to residues 57–73
of the rat TASK3 protein (1:1000, Alomone labs, Israel). The antibody
against TASK1 (Figure 5F) was a rabbit polyclonal antibody (Kindler
et al., 2000; Lopes et al., 2000; Millar et al., 2000) raised against the
peptide (C)EDEK RDAEH RALLT RNGQ corresponding to residues
252–269 of human TASK1 (1:1000, Alomone Labs, Jerusalem, Israel).
Slices were incubated with the primary antibodies overnight in PBS
containing 1% horse serum, 0.2% BSA, and 0.5% Triton, followed by
four washes in PBS. Subsequently, slices were incubated with sec-
ondary antibodies, chicken antirabbit IgG-Alexa Fluor 647 (1:1000,
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red (1:200, Santa Cruz Biotechnology), for 90 min in PBS containing
0.2% BSA and 0.5% Triton, followed by six washes in PBS. Slices
were then mounted on glass coverslips in Vectashield antibleach
mounting medium (Vector Laboratories, Peterborough, UK). For
negative controls, the primary antibodies were preincubated for
1 hr with control peptide antigens (1 mg of antigen per 1 mg of anti-
body) provided with the antibodies. All the chemicals were from
Sigma unless stated otherwise. Slices were analyzed using a Leica
Microsystems TCS SL confocal laser-scanning microscope (Man-
nheim, Germany). eGFP, Texas red, and Alexa Fluor 647 were
excited at 477 nm, 543 nm, and 633 nm, respectively, and emission
was detected at 490–550 nm, 570–620 nm, and 660–740 nm, respec-
tively. For optimal separation of fluorescent signals, the sequential
‘‘between lines’’ scanning mode of the microscope was used.
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